Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with 99mTc, 111In and 125I

被引:53
作者
Hofstrom, Camilla [2 ]
Orlova, Anna [1 ]
Altai, Mohamed [1 ]
Wangsell, Fredrik [3 ]
Graslund, Torbjorn [2 ]
Tolmachev, Vladimir [1 ]
机构
[1] Uppsala Univ, Div Biomed Radiat Sci, Rudbeck Lab, Uppsala, Sweden
[2] Royal Inst Technol, Dept Mol Biotechnol, Stockholm, Sweden
[3] Uppsala Univ, Dept Med Chem, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
ANTI-HER2; AFFIBODY; HER2; EXPRESSION; HER2-EXPRESSING TUMORS; RECOMBINANT PROTEINS; MALIGNANT-TUMORS; PEPTIDE; AFFINITY; TECHNETIUM; SCAFFOLD; THERAPY;
D O I
10.1021/jm200065e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Affibody molecules are a class of small (similar to 7 kDa) robust scaffold proteins suitable for radionuclide molecular imaging in vivo. The attachment of a hexahistidine (His(6))-tag to the Affibody molecule allows facile purification by immobilized metal ion affinity chromatography (IMAC) but leads to high accumulation of radioactivity in the liver. Earlier, we have demonstrated that replacement of the His(6)- tag with the negatively charged histidine-glutamate-histidine-glutamate-histidine-glutamate (HEHEHE)-tag permits purification of Affibody molecules by IMAC, enables labeling with [Tc-99m(CO)(3)](+), and provides low hepatic accumulation of radioactivity. In this study, we compared the biodistribution of cysteine-containing Affibody molecules site-specifically labeled with In-111, Tc-99m, and I-125 at the C-terminus, having a His(6)-tag at the N- or C-terminus or a HEHEHE-tag at the N-terminus. We show that the use of a HEHEHE-tag provides appreciable reduction of hepatic radioactivity, especially for radiometal labels. We hope that this information can also be useful for development of other scaffold protein-based imaging agents.
引用
收藏
页码:3817 / 3826
页数:10
相关论文
共 41 条
  • [1] ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO
  • [2] 2-7
  • [3] Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules
    Ahlgren, Sara
    Orlova, Anna
    Rosik, Daniel
    Sandstrom, Mattias
    Sjoberg, Anna
    Basstrup, Barbo
    Widmark, Olof
    Fant, Gunilla
    Feldwisch, Joachim
    Tolmachev, Vladimir
    [J]. BIOCONJUGATE CHEMISTRY, 2008, 19 (01) : 235 - 243
  • [4] Radionuclide Molecular Imaging Using Affibody Molecules
    Ahlgren, Sara
    Tolmachev, Vladimir
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (06) : 581 - 589
  • [5] Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold
    Ahlgren, Sara
    Orlova, Anna
    Wallberg, Helena
    Hansson, Monika
    Sandstrom, Mattias
    Lewsley, Richard
    Wennborg, Anders
    Abrahmsen, Lars
    Tolmachev, Vladimir
    Feldwisch, Joachim
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (07) : 1131 - 1138
  • [6] Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine
    Ahlgren, Sara
    Andersson, Kristofer
    Tolmachev, Vladimir
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (05) : 539 - 546
  • [7] Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
    Ahlgren, Sara
    Wallberg, Helena
    Tran, Thuy A.
    Widstrom, Charles
    Hjertman, Magnus
    Abrahmsen, Lars
    Berndorff, Dietmar
    Dinkelborg, Ludger M.
    Cyr, John E.
    Feldwisch, Joachim
    Orlova, Anna
    Tolmachev, Vladimir
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (05) : 781 - 789
  • [8] Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
    Baum, Richard P.
    Prasad, Vikas
    Mueller, Dirk
    Schuchardt, Christiane
    Orlova, Anna
    Wennborg, Anders
    Tolmachev, Vladimir
    Feldwisch, Joachim
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) : 892 - 897
  • [9] Berndorff D, 2006, J NUCL MED, V47, P1707
  • [10] IMMOBILIZED-METAL AFFINITY CHROMATOGRAPHY (IMAC): A REVIEW
    Block, Helena
    Maertens, Barbara
    Spriestersbach, Anne
    Brinker, Nicole
    Kubicek, Jan
    Fabis, Roland
    Labahn, Joerg
    Schaefer, Frank
    [J]. GUIDE TO PROTEIN PURIFICATION, SECOND EDITION, 2009, 463 : 439 - 473